Literature DB >> 667443

Trimethoquinol is a potent prostaglandin endoperoxide antagonist [proceedings].

D E MacIntyre, A L Willis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 667443      PMCID： PMC1668339     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  5 in total

1.  Inhibition of platelet aggregation by papaverine-like drugs: evidence for a novel mechanism of action.

Authors:  G Shtacher; H J Crowley; C Dalton
Journal:  Biochem Pharmacol       Date:  1976-05-01       Impact factor: 5.858

2.  Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins.

Authors:  D E MacIntyre; J L Gordon
Journal:  Thromb Res       Date:  1977-12       Impact factor: 3.944

3.  Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides.

Authors:  P Needleman; S Moncada; S Bunting; J R Vane; M Hamberg; B Samuelsson
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

4.  An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance.

Authors:  A L Willis; F M Vane; D C Kuhn; C G Scott; M Petrin
Journal:  Prostaglandins       Date:  1974-12-25

5.  A simple fluorimetric microassay for adenine compounds in platelets and plasma and its application to studies on the platelet release reaction.

Authors:  J L Gordon; A H Drummond
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857
  5 in total
  2 in total

1.  Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.

Authors:  R A Coleman; P P Humphrey; I Kennedy; G P Levy; P Lumley
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

2.  Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.

Authors:  L G Carmo; M Hatmi; D Rotilio; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.